Company Filing History:
Years Active: 2020-2022
Title: Brian T Chamberlain: Innovator in Pharmaceutical Modulation
Introduction
Brian T Chamberlain is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of the stimulator of interferon genes (STING) protein. With a total of 2 patents, his work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Chamberlain's latest patents include innovative compounds known as oxoacridinyl acetic acid derivatives. These compounds, or their pharmaceutically acceptable salts or esters, are capable of binding to and modulating the activity of the STING protein. The methods involving these compounds as effective modulators of STING are also outlined in his patents, showcasing their potential utility in medical applications.
Career Highlights
Throughout his career, Brian T Chamberlain has worked with several companies, including Stingthera, Inc. and Silicon Swat, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research.
Collaborations
Chamberlain has collaborated with notable individuals in his field, including James M Rice and Finith E Jernigan, III. These collaborations have likely enriched his work and expanded the scope of his inventions.
Conclusion
Brian T Chamberlain stands out as an influential inventor in the pharmaceutical industry, with a focus on STING modulation. His contributions through his patents and collaborations highlight his commitment to advancing medical science.